MedPlus files FY26 BRSR highlighting ESG goals and CSR initiatives

2 min read     Updated on 26 Jul 2026, 04:19 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

MedPlus Health Services Limited submitted its Business Responsibility and Sustainability Report for FY2026, outlining operational metrics, environmental strategies, and governance frameworks. The filing reveals a workforce of 27,686 employees, significant CSR investments, and adherence to NGRBC principles without external audit verification.

powered bylight_fuzz_icon
46371840

*this image is generated using AI for illustrative purposes only.

MedPlus Health Services Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 to the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). The filing, dated July 23, 2026, was signed by Company Secretary Shrenik Soni and complies with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report outlines the company’s environmental, social, and governance (ESG) performance, including workforce data, sustainability practices, and corporate social responsibility (CSR) activities.

Operational Footprint and Workforce

MedPlus operates as one of India’s largest retail pharmacy chains, serving consumers across 14 states. Approximately 90% of its operations are conducted through its subsidiary, Optival Health Solutions Private Limited (OHSPL), which is included in the reporting boundary. The company maintains a network of 5,714 locations nationwide, comprising 5 national plants and 5,709 offices or outlets. There are no international operations, and export contribution stands at 0%.

As of the end of FY2026, MedPlus employed 27,686 permanent employees, with females constituting 31.76% of the workforce. The company reported no permanently employed workers or differently abled employees. Key workforce metrics are summarized below:

Metric Value
Total Permanent Employees 27,686
Female Representation 31.76%
Differently Abled Employees 0
Board Members 6 (1 Female)
Key Managerial Personnel 4

The median annual remuneration for directors was ₹10,50,000 for males and ₹10,00,000 for females. Key Managerial Personnel received a median annual remuneration of ₹73,02,562. The company provided health and accident insurance coverage to 100% of permanent employees. Maternity benefits covered 14.09% of total permanent employees (3,900 individuals), while day care facilities were available for 5,252 male and 2,764 female employees.

Environmental Stewardship and Governance

MedPlus has implemented several environmental initiatives, including the transition from single-use plastic bags to compostable bags in stores and the use of recyclable plastic bags and biodegradable covers in warehouses. The company is replacing lighting with energy-efficient alternatives and monitoring energy consumption across its network. Waste management involves recycling plastic and e-waste through third-party providers, while hazardous waste is managed by authorized specialists.

Governance policies aligned with all nine National Guidelines on Responsible Business Conduct (NGRBC) principles have been approved by the Board. These policies are reviewed annually for performance-related matters and quarterly for compliance-related matters. No external agency was engaged for independent assessment of these policies; oversight is maintained through internal audits and Board committee reviews. The company reported zero fines, penalties, or non-monetary sanctions during the year.

CSR and Stakeholder Engagement

During FY2026, MedPlus executed 15 CSR projects, all targeting vulnerable and marginalized groups. Notable initiatives included the Sir C.V. Raman Akshaya Science Centre (250 beneficiaries), Student Mobility Support Programme (97 beneficiaries), Solar Panels for farmers in Adilabad district (100 beneficiaries), and an Ambulance project (1,000 beneficiaries). The company engages with stakeholders—including patients, employees, suppliers, and regulators—through various channels such as retail interactions, social media, and shareholder meetings. A comprehensive materiality assessment involving all stakeholder groups was conducted to identify key ESG issues.

Financial Disclosures

The BRSR discloses the following standalone financial parameters for the reporting period:

Parameter Value
Standalone Net Worth ₹13,161.13 Million

The standalone turnover figure was referenced but not fully disclosed in the filing. The report emphasizes that product information disclosures covering environmental, social, and safe usage parameters are provided on 100% of products as a percentage of total turnover. No voluntary or forced product recalls, nor any data breaches, were reported during the period.

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-6.25%-19.38%-22.80%-19.33%-41.44%

How might MedPlus's rapid expansion to 5,714 locations impact its ability to maintain consistent ESG compliance and waste management standards across all outlets?

What strategies is MedPlus planning to implement to increase female representation in its workforce and board, given the current 31.76% female employee ratio and only one female board member?

Could the absence of differently abled employees in its permanent workforce expose MedPlus to reputational risks or future regulatory scrutiny under India's Rights of Persons with Disabilities Act?

Medplus Health Services
View Company Insights
View All News
like16
dislike

MedPlus Health Services seeks approval to re-appoint MD & CEO at AGM

3 min read     Updated on 23 Jul 2026, 10:20 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

MedPlus Health Services Limited convenes its 20th AGM on August 17, 2026, focusing on key governance decisions. Shareholders will vote to re-appoint Gangadi Madhukar Reddy as MD & CEO for a five-year term and approve the induction of two new independent directors, Mohan Krishna Reddy and Ajit Pandurang Rangnekar, both serving five-year terms. The meeting also includes the ratification of cost auditor remuneration for M/s. M P R & Associates for FY27.

powered bylight_fuzz_icon
46283722

*this image is generated using AI for illustrative purposes only.

MedPlus Health Services has scheduled its 20th Annual General Meeting (AGM) for Monday, August 17, 2026, to approve critical board appointments and financial resolutions. The meeting, conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), will see shareholders vote on the re-appointment of Managing Director & CEO Gangadi Madhukar Reddy for a five-year term, alongside the induction of two new independent directors. This governance update follows the company’s filing of its FY26 Annual Report, which reported a consolidated revenue of ₹68,924.66 million and a profit after tax of ₹2,196.06 million.

The AGM agenda includes ordinary business items such as the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. Dr. Cherukupalli Bhaskar Reddy, Whole Time Director, retires by rotation and seeks re-appointment. Shareholders holding shares as of the cut-off date, August 10, 2026, are eligible to participate in remote e-voting, which opens on August 14, 2026, at 09:00 AM IST and closes on August 16, 2026, at 05:00 PM IST.

Key Resolutions and Board Appointments

The special business section of the AGM focuses on strengthening the board’s composition with diverse expertise. The Nomination and Remuneration Committee recommended the appointment of Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors. Both appointments require special resolutions under Regulation 17(1A) of the SEBI LODR Regulations due to their age exceeding or approaching 75 years.

Director Name Designation Term Start Term End Age Key Expertise
Mohan Krishna Reddy Independent Director May 20, 2026 May 19, 2031 70 Finance, Strategy, Investment Banking
Ajit Pandurang Rangnekar Independent Director May 20, 2026 May 19, 2031 79 Manufacturing, Supply Chain, Consulting

Mr. Mohan Krishna Reddy brings over three decades of experience in finance and strategy, including roles at Indian Bank, Unit Trust of India, and JM Financial. Mr. Ajit Pandurang Rangnekar offers more than 50 years of leadership experience across manufacturing, services, and consulting sectors, including a B.Tech from IIT Bombay and a PGP from IIM Ahmedabad.

Re-appointment of Managing Director & CEO

Shareholders will also vote on the re-appointment of Gangadi Madhukar Reddy as Managing Director & CEO for a period of five years, commencing August 03, 2026, and ending August 02, 2031. His consolidated remuneration is capped at ₹4.00 million per annum, subject to limits prescribed under the Companies Act, 2013. In the event of inadequate profits, his remuneration will adhere to Schedule V of the Act. Mr. Reddy, who holds an MBA from Wharton School, has been instrumental in driving the company’s expansion to over 5,330 stores across 13 states and one union territory.

Auditor Ratification and Governance

The AGM will also ratify the remuneration of M/s. M P R & Associates, Cost Accountants, as Cost Auditors for FY27. The approved fee is ₹1,50,000 plus applicable taxes and out-of-pocket expenses. The Statutory Auditors for FY26 were M/s. B S R and Co., which issued an unqualified audit report. The Secretarial Audit by M/s. R & A Associates contained no qualifications.

E-Voting and Meeting Logistics

KFin Technologies Limited serves as the Registrar and Transfer Agent and e-voting service provider. Members can cast votes via remote e-voting using credentials linked to their demat accounts or physical folios. The facility for attending the AGM virtually is available on a first-come, first-served basis for up to 1,000 members, excluding large shareholders, promoters, and institutional investors. Questions from members must be submitted at least 72 hours before the AGM via the designated email IDs or the e-voting portal.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE804L01022/998fd76c-9619-414c-9115-3279df5d440e.pdf

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-6.25%-19.38%-22.80%-19.33%-41.44%

How might the addition of independent directors with deep expertise in finance and supply chain influence MedPlus's strategy for optimizing its extensive store network and inventory management?

Given the re-appointment of the CEO for a five-year term, what specific growth targets or expansion plans into new states or digital health services are likely to be prioritized for FY27?

Will the appointment of directors nearing or exceeding the age of 75 under special resolutions signal a shift towards long-term stability in governance, or could it raise concerns about leadership succession planning?

Medplus Health Services
View Company Insights
View All News
like20
dislike

More News on Medplus Health Services

1 Year Returns:-19.33%